Skip to Main Content

Paper Details

Recurrent and functional regulatory mutations in breast cancer.
Nature
207
2017
E2F, FOXA1, NEAT1, RMRP, breast cancer, breast cancers, cancer, cancer genes, coding regions, hormone, hormone-receptor positive breast cancer, mutated promoters, mutational hotspot, non, non-coding RNA genes, non-coding regions, patients, promoter, promoter regions, promoters, protein-coding regions, tumours
Author NameAffiliation
Esther RheinbayThe Broad Institute of MIT and Harvard
Esther RheinbayMassachusetts General Hospital Center for Cancer Research
Jonna GrimsbyThe Broad Institute of MIT and Harvard
Grace TiaoThe Broad Institute of MIT and Harvard
Jesse M EngreitzThe Broad Institute of MIT and Harvard
Jesse M Engreitz
Jaegil KimThe Broad Institute of MIT and Harvard
Michael S LawrenceThe Broad Institute of MIT and Harvard
Michael S LawrenceMassachusetts General Hospital Center for Cancer Research
Amaro Taylor-WeinerThe Broad Institute of MIT and Harvard
Sergio Rodríguez-CuevasInstituto de Enfermedades de la Mama FUCAM
Mara RosenbergThe Broad Institute of MIT and Harvard
Mara RosenbergThe Broad Institute of MIT and Harvard
Julian M HessThe Broad Institute of MIT and Harvard
Julian M HessThe Broad Institute of MIT and Harvard
Chip StewartThe Broad Institute of MIT and Harvard
Chip StewartThe Broad Institute of MIT and Harvard
Petar StojanovThe Broad Institute of MIT and Harvard
Maria L CortésThe Broad Institute of MIT and Harvard
Sara SeepoThe Broad Institute of MIT and Harvard
Adam TracyThe Broad Institute of MIT and Harvard
Trevor J PughPrincess Margaret Cancer Centre, University Health Network and the Department of Medical Biophysics, University of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network and the Department of Medical Biophysics, University of Toronto
Anthony J IafrateMassachusetts General Hospital Center for Cancer Research
Jesse S BoehmThe Broad Institute of MIT and Harvard
Jesse S BoehmThe Broad Institute of MIT and Harvard
Stacey GabrielThe Broad Institute of MIT and Harvard
Stacey GabrielThe Broad Institute of MIT and Harvard
Matthew MeyersonThe Broad Institute of MIT and Harvard
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonHarvard Medical School
Matthew MeyersonThe Broad Institute of MIT and Harvard
Matthew MeyersonDana-Farber Cancer Institute
Matthew MeyersonHarvard Medical School
Todd R GolubThe Broad Institute of MIT and Harvard
Todd R GolubDana-Farber Cancer Institute
Todd R GolubHarvard Medical School
Todd R GolubThe Broad Institute of MIT and Harvard
Todd R GolubDana-Farber Cancer Institute
Todd R GolubHarvard Medical School
José BaselgaMemorial Sloan Kettering Cancer Center
Alfredo Hidalgo-MirandaInstituto Nacional de Medicina Genomica
Eric S LanderThe Broad Institute of MIT and Harvard
Eric S LanderThe Broad Institute of MIT and Harvard
Gad GetzMassachusetts General Hospital Center for Cancer Research
Gad GetzHarvard Medical School
Gad GetzMassachusetts General Hospital
Gad GetzThe Broad Institute of MIT and Harvard
Gad GetzThe Broad Institute of MIT and Harvard
Gad GetzMassachusetts General Hospital Center for Cancer Research
  • 1 - 50

Datasets